Patrick K Ha
Overview
Explore the profile of Patrick K Ha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
2908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Truong A, Lee R, Wu X, Algazi A, Kang H, El-Sayed I, et al.
Otolaryngol Head Neck Surg
. 2024 Dec;
172(2):548-555.
PMID: 39675043
Objective: To determine the relationship between pretreatment neutrophil-to-lymphocyte ratio (NLR) and 6-month progression-free survival (PFS)/2-year overall survival (OS) among patients with recurrent or metastatic (R/M) oral cavity cancer on pembrolizumab....
2.
Wai K, Okholm T, Ha P, Marquez D, Tenvooren I, Jones K, et al.
Head Neck
. 2024 Mar;
46(7):1625-1636.
PMID: 38454566
Background: Treatment of salivary gland tumors (SGTs) remains challenging. Little is known about the immune landscape of SGTs. We aimed to characterize the tumor microenvironment in benign and malignant SGTs....
3.
Abdulbaki H, Ha P, Knott P, Park A, Seth R, Heaton C, et al.
Head Neck
. 2024 Mar;
46(10):2432-2439.
PMID: 38445792
Background: Complications following head and neck microvascular free tissue transfer (MFTT) are common. Less is known about when they occur. Method: Retrospective study of patients with primary or recurrent head...
4.
Jiam M, Xin K, Ha P, Jiam N
Head Neck
. 2024 Feb;
46(5):1001-1008.
PMID: 38344931
Background: New patient referrals are often processed by practice coordinators with little-to-no medical background. Treatment delays due to incorrect referral processing, however, have detrimental consequences. Identifying variables that are associated...
5.
Souza S, Stephens E, Bourdillon A, Bhethanabotla R, Farzal Z, Plonowska-Hirschfeld K, et al.
Am J Otolaryngol
. 2023 Dec;
45(2):104184.
PMID: 38101135
Purpose: To understand the utility of circulating tumor human papillomavirus DNA (ctHPVDNA) blood testing for HPV-associated oropharynx squamous cell carcinoma (HPV + OPSCC) after definitive surgery. Materials And Methods: Prospective...
6.
Lee R, Truong A, Wu X, Kang H, Algazi A, El-Sayed I, et al.
Head Neck
. 2023 Oct;
46(1):129-137.
PMID: 37897202
Background: A minority of patients with recurrent/metastatic (R/M) salivary gland cancers (SGCs) benefit from immune checkpoint inhibitors (ICIs), necessitating reliable biomarkers for ICI response prediction. Methods: Retrospective observational study of...
7.
Plonowska-Hirschfeld K, Gulati A, Stephens E, Ochoa E, Xu M, Ha P, et al.
Laryngoscope
. 2023 Sep;
134(4):1687-1695.
PMID: 37767815
Objective: To prospectively compare the impact of treatment modality on patient-reported quality of life (QOL) in human papillomavirus-associated oropharynx squamous cell carcinoma (HPV + OPSCC). Study Design: Prospective cohort study....
8.
Kuan E, Wang E, Adappa N, Beswick D, London Jr N, Su S, et al.
Int Forum Allergy Rhinol
. 2023 Sep;
14(2):149-608.
PMID: 37658764
Background: Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represent a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus...
9.
Ndon S, Singh A, Ha P, Aswani J, Chan J, Xu M
Cancers (Basel)
. 2023 Aug;
15(16).
PMID: 37627108
Global trends in human papillomavirus (HPV)-associated head and neck cancers (HNC), specifically in the oropharynx subsite, have been dynamically changing, leading to new staging and treatment paradigms. Epidemiologic studies have...
10.
Gulati A, Plonowska-Hirschfeld K, Stephens E, Kansara S, Zebolsky A, Ochoa E, et al.
Clin Otolaryngol
. 2023 May;
48(5):756-765.
PMID: 37212448
Objectives: To compare post-treatment neck and shoulder function between human papillomavirus-associated oropharynx squamous cell carcinoma (HPV + OPSCC) treatments. Design: Prospective, repeated-measures study. Setting: Tertiary care center. Participants: Treatment-naïve patients...